France Christopher R, al'Absi Mustafa, Ring Christopher, France Janis L, Harju Angie, Wittmers Lorentz E
Department of Psychology, Ohio University, Athens, OH 45701, USA.
Biol Psychol. 2007 Apr;75(1):95-100. doi: 10.1016/j.biopsycho.2006.12.005. Epub 2006 Dec 27.
The effect of opioid blockade on nociceptive flexion reflex (NFR) activity and subjective pain ratings was examined in 151 healthy young men and women. Using a within-subjects design, NFR threshold was assessed on 2 days after administration of either placebo or a 50mg dose of naltrexone. Electrocutaneous pain threshold and tolerance levels were measured after NFR threshold assessment on each day. Results indicated that administration of naltrexone was consistently associated with hypoalgesic responding. Specifically, participants exhibited lower levels of NFR activity and reported lower pain ratings for electrocutaneous stimulation delivered at pain threshold and tolerance levels following administration of naltrexone as compared to placebo. These findings indicate that opiate blockade using the current standard dose may elicit hypoalgesia. A potential moderating effect of dose of opiate-blockade medication and level of endogenous opioid activation should be carefully examined in future research.
在151名健康的年轻男性和女性中,研究了阿片类药物阻断对伤害性屈曲反射(NFR)活动和主观疼痛评分的影响。采用受试者内设计,在给予安慰剂或50mg剂量纳曲酮后的2天评估NFR阈值。每天在NFR阈值评估后测量皮肤电刺激疼痛阈值和耐受水平。结果表明,纳曲酮的给药始终与痛觉减退反应相关。具体而言,与安慰剂相比,参与者在服用纳曲酮后,NFR活动水平较低,并且在疼痛阈值和耐受水平下进行皮肤电刺激时报告的疼痛评分较低。这些发现表明,使用当前标准剂量的阿片类药物阻断可能会引起痛觉减退。在未来的研究中,应仔细研究阿片类药物阻断药物剂量和内源性阿片类药物激活水平的潜在调节作用。